Advertisement
UK markets closed
  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     
  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     
  • CRUDE OIL

    78.97
    +0.59 (+0.75%)
     
  • GOLD FUTURES

    2,319.90
    -4.30 (-0.19%)
     
  • DOW

    39,041.01
    +156.75 (+0.40%)
     
  • Bitcoin GBP

    50,181.68
    -332.33 (-0.66%)
     
  • CMC Crypto 200

    1,329.57
    +34.90 (+2.70%)
     
  • NASDAQ Composite

    16,305.78
    -26.78 (-0.16%)
     
  • UK FTSE All Share

    4,544.24
    +21.25 (+0.47%)
     

Analyst Recommendations for Valeant Pharmaceuticals in July

Analyst Recommendations for Valeant Pharmaceuticals in July

In July, the FDA accepted Bausch + Lomb’s NDA (New Drug Application) for sub-micron loteprednol etabonate for the treatment of patients who have undergone ocular surgery and are showing symptoms of post-operative inflammation and pain.